We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Investigational Device Monitors Venous Waveform

By HospiMedica International staff writers
Posted on 05 Jul 2021
Print article
Image: The NIVA HF wristband captures the venous waveform (Photo courtesy of VoluMetrix)
Image: The NIVA HF wristband captures the venous waveform (Photo courtesy of VoluMetrix)
A novel non-invasive venous waveform analysis (NIVA) device provides a proprietary score that corresponds to pulmonary capillary wedge pressure (PCWP).

The VoluMetrix (Nashville, TN, USA) NIVA HF device is designed to capture the venous waveform, an energy-based signal generated by the heart and respiratory activity that reflects numerous physiologic conditions, including pulse rate, respiration, and intravascular and extravascular dynamics. It serves as a non-invasive indicator of volume status and the presence of congestion in patients with heart failure (HF).

The device is based on a non-invasive wrist sensor that identifies multiple frequencies that are first deconstructed by mapping individual amplitudes within a patient's waveform, and subsequently decoded by a proprietary algorithm. The result is the NIVA score, which provides cardiologists and other healthcare professionals (and their patients) with a simple measure that parallels to PCWP, a well-recognized and clinically relevant assessment of volume status. Using PCWP to evaluate blood volume status is especially important when fluids are administered during hypotensive shock.

“NIVA HF is the culmination of our organization's talent, intellect, passion, and hard work. It represents the first of many potential vehicles for our NIVA vital monitoring technology,” said Kyle Hocking, PhD, President and CEO of VoluMetrix. “Ultimately, our mission is to improve the care experience for as many heart failure patients as possible, as quickly as possible.”

PCWP provides an indirect estimate of left atrial pressure (LAP), and can help quantify the severity of left ventricular failure and the degree of mitral valve stenosis, aortic valve stenosis and regurgitation, mitral regurgitation, and pulmonary hypertension. By measuring PCWP, the physician can titrate the dose of diuretic and other drugs that are used to reduce pulmonary venous and capillary pressure, and thereby reduce pulmonary edema.

Related Links:
VoluMetrix

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
LED Phototherapy System
Bililed Mini+

Print article

Channels

Surgical Techniques

view channel
Image: Computational models can predict future structural integrity of a child’s heart valves (Photo courtesy of 123RF)

Computational Models Predict Heart Valve Leakage in Children

Hypoplastic left heart syndrome is a serious birth defect in which the left side of a baby’s heart is underdeveloped and ineffective at pumping blood, forcing the right side to handle the circulation to... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.